Hideharu Kimura

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.

Yutaka Yonemura, Itasu Ninomiya, A Yamaguchi et al. · PubMed · 1991 · 336 citations

Tumor Biology, Gastrointestinal Oncology, Medicine +12

Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer

Hideharu Kimura, Kazuo Kasahara, Makoto Kawaishi et al. · Clinical Cancer Research · 2006 · 324 citations · Full text

Non–small-cell Lung Cancer, Serum Dna, Molecular Diagnostic Techniques +14

Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor

Hideharu Kimura, Kazuko Sakai, Tokuzo Arao et al. · Cancer Science · 2007 · 276 citations · Full text

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)

Hideharu Kimura, Mika Suminoe, Kazuo Kasahara et al. · British Journal of Cancer · 2007 · 204 citations · Full text

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Tokuzo Arao, Kazuomi Ueshima, Tomoyuki Nagai et al. · Hepatology · 2012 · 152 citations · Full text